Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Expressing Solution Concentration

Expressing Solution Concentration

A solute is a component of a solution that is typically present at a much lower concentration than the solvent. Solute concentrations are often described with qualitative terms such as dilute (of relatively low concentration) and concentrated (of relatively high concentration).
Concentrations may be quantitatively assessed using a wide variety of measurement units, each convenient for particular applications. Molarity (M) is a useful concentration unit for many applications in chemistry.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular neighbours reshape protein dynamics.

Nature chemistry·2026

Same author

A machine learning approach to identify active polysorbate 20 degrading hydrolases in biopharmaceutical formulations.

Journal of pharmaceutical sciences·2026

Same author

Capturing transient states of heterodimeric ABC transporter TM287/288 by time-resolved small-angle X-ray scattering.

Biophysical journal·2026

Same author

Glycan pairing in therapeutic IgG orchestrates Fcγ receptor engagement and ADCC: an integrated structure-function approach for thorough evaluation of Fc N-glycans as critical quality attributes.

mAbs·2026

Same author

Phosphatidylcholine-Polysorbate 20-Based Mixed Micelles: A New Option to Prevent Protein Aggregation?

Pharmaceutics·2026

Same author

Selective clearance of monoclonal antibodies via the mannose receptor is dependent on glycan pairing.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Feb 27, 2026

Designing Silk-silk Protein Alloy Materials for Biomedical Applications

Designing Silk-silk Protein Alloy Materials for Biomedical Applications

Published on: August 13, 2014

High-concentration protein formulations: How high is high?

Patrick Garidel¹, Alexander B Kuhn², Lars V Schäfer²

¹Boehringer Ingelheim Pharma GmbH & Co. KG, Corporate Division Biopharmaceuticals, Process Science, Protein Science, Biberach an der Riss, Germany.

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V

|July 11, 2017

Summary

Developing high-concentration protein formulations (HCPF) presents challenges. Theoretical limits suggest monoclonal antibody concentrations above 500mg/ml are highly challenging to achieve, impacting drug development strategies.

Keywords:

Colloidal properties Formulation HCLF HCPF High-concentration Monoclonal antibody Packing characteristics Protein Solubility

More Related Videos

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

Related Experiment Videos

Last Updated: Feb 27, 2026

Designing Silk-silk Protein Alloy Materials for Biomedical Applications

Designing Silk-silk Protein Alloy Materials for Biomedical Applications

Published on: August 13, 2014

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

Area of Science:

Biopharmaceutical Development
Protein Chemistry
Formulation Science

Background:

High-concentration protein formulations (HCPF), often involving monoclonal antibodies (mAbs), exhibit unique properties like high viscosity and particle formation.
Current definitions for HCPF concentrations vary, typically ranging from 50-150 mg/ml for mAbs.

Purpose of the Study:

To investigate the theoretical maximum achievable concentrations for high-concentration protein formulations.
To identify key challenges in developing stable and effective protein therapeutics at elevated concentrations.

Main Methods:

Utilized geometrical packing models to estimate theoretical concentration limits for monoclonal antibodies.
Compared different packing assumptions and discussed their relevance, considering physicochemical properties like solubility.

Main Results:

Theoretical estimations indicate that achieving monoclonal antibody concentrations exceeding 500 mg/ml in HCPF is likely to be very challenging.
The study highlights the limitations of simple geometrical models in predicting solubility at high concentrations.

Conclusions:

The findings provide insights into the realistic achievable concentration ranges for HCPF.
Results have implications for strategic planning in biopharmaceutical drug product development and target product profiles.